Zydus Lifesciences : Q4 & FY26 EARNINGS HIGHLIGHTS 📊💊
💰 Financial Performance
• Q4 Revenue at ₹7,587 Cr ↑ 16.2% YoY
• Q4 EBITDA at ₹2,554 Cr ↑ 20.2% YoY
• EBITDA Margins expanded to 33.7% vs 32.6% YoY
• Q4 Net Profit at ₹1,272 Cr ↑ 8.7% YoY
• R&D expenses rose 45.5% YoY to ₹698 Cr
• FY26 Revenue at ₹27,148 Cr ↑ 16.8% YoY
• FY26 EBITDA at ₹8,475 Cr ↑ 20.1% YoY
• FY26 Net Profit at ₹5,040 Cr ↑ 11.4% YoY
RATNAMANI METALS & TUBES LTD – Q4FY26 CONCALL HIGHLIGHTS
#Q4FY26
🔹 MANAGEMENT
• Challenging environment impacted execution
• Middle East tensions disrupted demand
• Operational resilience remained strong
• Resource conservation became key priority
• Product mix supported stable margins
🔹 OUTLOOK
• FY27 revenue target ₹4,800-5,000 Cr
• RTF growth guided at 10-15%
• RFSS growth guided at 20-25%
• Margins targeted at 16-18%
• Order book ensured revenue visibility
🔹 INDUSTRY
• Shipping costs surged sharply globally
• Oil & gas projects slowed temporarily
• Nuclear sector demand remained strong
• CGD demand expected to recover
• Thermal and renewable additions accelerating
🔹 COMPETITIVE POSITION
• Competition increasing in stainless steel
• Focus shifted toward extruded products
• Nuclear-approved facility created strong moat
• High-value segments strengthened positioning
• Extrusion reliability remained differentiator
🔹 RISKS
• Middle East conflict disrupted logistics
• Customers resisted elevated freight charges
• Copied From Concalls3 Telegram channel
• Gas cost inflation impacted operations
• Piercing technology pressured margins temporarily
• Carbon steel demand remained weak
🔹 GROWTH DRIVERS
• Nuclear spooling emerged major driver
• Saudi Arabia project progressing steadily
• 18m pipe manufacturing capability added
• Copied From Concalls3 Telegram channel
• Auto parts expansion underway at RTF
• Defense and aerospace opportunities rising
🔹 PRODUCT MIX
• Carbon steel volumes declined YoY
• Stainless steel volumes improved steadily
• Higher realizations supported profitability
• Value-added products gaining contribution
• Order book favored carbon steel
🔹 FY26 FINANCIALS
• Revenue stood at ₹4,494 Cr
• EBITDA remained broadly stable YoY
• Standalone entity stayed debt-free
• Cash balance stood at ₹800 Cr
• Copied From Concalls3 Telegram channel
• Dividend recommended at ₹10/share
🔹 KEY HIGHLIGHTS
• Strong balance sheet supported stability
• RFSS became landmark growth vertical
• Operational efficiency protected profitability
• High-value focus reduced cyclicality
• Recovery outlook tied to normalization
MPS LTD – Q4FY26 CONCALL HIGHLIGHTS
#Q4FY26
🔹 MANAGEMENT
• FY26 became most profitable year
• AI-first knowledge platform strategy accelerated
• Operating system reset completed successfully
• Capital discipline remained core focus
• High-stakes AI workflows prioritized
🔹 OUTLOOK
• FY27 EBITDA guided above ₹300 Cr
• FY28 revenue target ₹1,500 Cr intact
• Research segment to contribute majority
• Unbound margins expected improving steadily
• Organic and M&A growth pipelines strong
🔹 INDUSTRY
• AI disrupting commoditized production services
• Demand rising for verified AI workflows
• Research integrity concerns accelerating globally
• Accessibility solutions gaining strong traction
• Remote work improving operating margins
🔹 COMPETITIVE POSITION
• Positioned at critical workflow control points
• MPS Labs created structural technology moat
• Domain expertise reduced AI hallucination risks
• Product-led strategy strengthened differentiation
• Copied From Concalls3 Telegram channel
• Large addressable market offered strong headroom
🔹 RISKS
• Commodity services facing pricing pressure
• Execution risk remained primary concern
• Corporate learning segment underwent reset
• Failure to adapt AI remains risk
• Low-margin work intentionally exited
🔹 GROWTH DRIVERS
• Hyperactive M&A pipeline progressing strongly
• Unbound Medicine expanded medical presence
• Copied From Concalls3 Telegram channel
• AI products deployed at scale
• APAC expansion focused on China, Japan
• Institutional recurring revenue increasing steadily
🔹 PRODUCT MIX
• Research segment shifted toward products
• Education business scaled accessibility solutions
• Corporate learning focused on simulations
• AI-assisted production gaining contribution
• Copied From Concalls3 Telegram channel
• Client diversification reduced concentration risks
🔹 FY26 FINANCIALS
• Revenue stood at ₹768 Cr
• EBITDA reached ₹236 Cr
• EBITDA margin improved to 30.7%
• PAT grew to ₹173 Cr
• ROCE remained strong at 38.2%
🔹 KEY HIGHLIGHTS
• AI-first transformation accelerated rapidly
• Dividend pause supported aggressive expansion
• Medical workflow presence strengthened materially
• High-margin recurring revenues increasing
• FY27 guidance reflected strong conviction
Read More article like this on sharepricenews.com
